|Articles|February 2, 2005

Infection in Breast Implants

Breast augmentation is the most frequent type of plastic surgery done in the United Kingdon and -- after nose reshaping and liposuction -- it is the third most common cosmetic procedure in the United States. However, infection complicates 2 percent to 2.5 percent of breast implantations, and is the leading cause of illness following such surgery. The comprehensive review in The LancetInfectious Diseases of infection of breast implants is particularly timely in light of the recent call for tighter regulation of the private cosmetic surgery industry in the United Kingdon

 

Professor Brigitte Pittet, of the plastic and reconstructive surgery unit, University of Geneva Hospitals, Geneva, Switzerland, and colleagues provide a fascinating journey through the history of breast implants and review the myriad risk factors for breast implant infections, before discussing clinical features such as toxic shock syndrome and late infection occurring months -- or even years -- after implantation. Diagnostic and management strategies are proposed for such problems.

 

In addition, they discuss the idea that capsular contraction -- the leading long-term complication that follows breast implantation, involving the formation and contraction of a collagenous sheath around the implant, thus forming hard, spherical masses in the breasts -- may be caused by subclinical infection, and could be prevented by antibiotics.

 

Pittet comments, Patients should be aware that, similar to other invasive procedures involving the implantation of foreign material, breast implants may lead to potential complications such as infection or capsular contracture. In good hands, however, infection remains infrequent.

 

Source: The Lancet Infectious Diseases


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.